Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bausch + Lomb Stock Pops
Why Bausch + Lomb Stock Soared by Over 7% on Monday
It was quite a busy and eventful day for the company.
Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid
Key Takeaways Bausch + Lomb shares surged Monday following reports Blackstone and TPG are considering teaming up to buy the eyecare company. A bid from Blackstone and TPG could reportedly value the company between $13 billion and $14 billion.
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
Bausch Health faces $21 billion in debt, with $10 billion due by 2027 and a $2.4 billion loan due next year. Private equity firms TPG and Blackstone are joining forces in a bid to acquire eye care company Bausch + Lomb BLCO, the Financial Times reported. Last month, Bausch + Lomb said it was considering a sale.
M&A News: TPG and Blackstone Could Eye Joint Bid for Bausch + Lomb (NYSE:BLCO)
Shares of contact lens supplier Bausch + Lomb ($BLCO) are surging in today’s trading amid news of a potential acquisition. According to an
Bausch & Lomb gains amid report TPG, Blackstone working on joint bid
Bausch & Lomb (NYSE:BLCO) jumped 9% in premarket trading on a report that private equity firms TPG (TPG) and Blackstone (BX) are working on a joint bid for the eyecare company. Several other PE shops that have been considering an offer have dropped out,
1d
Anticipated Private Equity Acquisition of Bausch + Lomb Corporation Offers Attractive Upside for Investors
In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating on Bausch + Lomb Corporation (BLCO – Research ...
3d
Bausch Health Companies (NYSE:BHC shareholders incur further losses as stock declines 4.4% this week, taking three-year losses to 72%
Bausch Health Companies Inc. ( NYSE:BHC ) shareholders should be happy to see the share price up 26% in the last ...
2d
Bausch + Lomb Shares Rise on FDA Approval of enVista Envy Intraocular Lens
Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...
1d
Evercore ISI Reaffirms Their Hold Rating on Bausch Health Companies (BHC)
In a report released today, Umer Raffat from Evercore ISI maintained a Hold rating on Bausch Health Companies (BHC – Research Report).
8d
on MSN
Paso Robles city manager files $2 million claim, alleging harassment from councilman
City Manager Ty Lewis is out on medical leave due to what he said is a hostile work environment in Paso Robles.
ophthalmologytimes
2d
FDA approves Bausch + Lomb’s enVista Envy range of IOLs
According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...
Opinion
Paso Robles Daily News
20h
Opinion
Opinion: Shining light on the latest Paso Robles City Hall drama
Sex parties. Corruption. Assault. Conspiracies. Vendettas. The latest drama coming out of Paso Robles City […] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback